Macroview Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Macroview Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-23	Closed	-$589	–	117
2024 Q3	$589	Hold	23	–	–	﹤0.01%	532
2024 Q2	$541	Hold	23	–	–	﹤0.01%	534
2024 Q1	$662	Sell	23 -40	-63%	-$1.2K	﹤0.01%	582
2023 Q4	$2.08K	Hold	63	–	–	﹤0.01%	524
2023 Q3	$1.76K	Hold	63	–	–	﹤0.01%	580
2023 Q2	$2.16K	Hold	63	–	–	﹤0.01%	395
2023 Q1	$1.9K	Hold	63	–	–	﹤0.01%	362
2022 Q4	$1.79K	Hold	63	–	–	﹤0.01%	373
2022 Q3	$2K	Sell	63 -34	-35%	-$1.25K	﹤0.01%	332
2022 Q2	$3K	Hold	97	–	–	﹤0.01%	334
2022 Q1	$4K	Buy	97 +1	+1%	+$48	0.01%	317
2021 Q4	$6K	Hold	96	–	–	0.01%	267
2021 Q3	$7K	Hold	96	–	–	0.01%	261
2021 Q2	$9K	Hold	96	–	–	0.01%	184
2021 Q1	$9K	Buy	96 +23	+32%	+$2.28K	0.01%	159
2020 Q4	$7K	Buy	+73	New	+$5.82K	0.01%	163

Other funds holding ARKG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Macroview Investment Management's ARKG Position: Q4 2024 in Review

Macroview Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 23 shares — an estimated $589 sold.

Macroview Investment Management first reported a position in ARKG in Q4 2020 and held it in 16 quarters. The position peaked at $9K in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

Macroview Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
Macroview Investment Management sold 23 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $589.
Macroview Investment Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 16 quarters.
Macroview Investment Management's ARK Genomic Revolution ETF position peaked at $9K in Q2 2021.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.